TCL Archive FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention” November 6, 1998
TCL Archive In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford March 11, 1977
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006